While ligands such as EGF, HGF, and PDGF can stimulate glioma invasion, blocking of these signaling pathways by anti-cancer drugs has not been so effective [78, 79] due to signal transduction redundancy in response to these drugs and co-expression of these molecules [80–84]. This evidence concerns the gene EGF and central nervous system cancer.